PPI Cases To Proceed as Per The New Deadlines Ordered
PPI Cases To Proceed as Per The New Deadlines Ordered
Introduction
Going forward, Proton Pump Inhibitor (PPI) cases will follow a number of new deadlines ordered by the federal court post the 5th Case Management Conference scheduled this November. Nearly 300 PPI cases are filed in the District of New Jersey by patients who developed renal issues allegedly linked to PPI usage. The drugs include Nexium, Prilosec, PrevAcid, and others.
Allegations hurled by the plaintiffs include that the defendants knew of the kidney failure and other kidney complications, yet failed to provide the patients and doctors with appropriate warnings.
All federally-filed PPI lawsuits were centralized in the District of New Jersey, for coordinated discovery and other pretrial proceedings in August, earlier this year, before Judge Claire C. Cecchi.
Comments
Latest News
Zimmer Biomet Gets FDA Approval for Cementless Partial Knee
Categories: Zimmer Hip/Knee Replacement
Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…
Court Names Special Masters for Bard Mesh Claim Settlements
Categories: Hernia Mesh
The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…
Baltimore Wins $266M in Opioid Case Against Drug Distributors
Categories: Opioids
Baltimore has secured a $266 million victory in its lawsuit against major drug distributors McKesson and Cencora (formerly AmerisourceBergen), accusing them of fueling the…